These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 20629660

  • 1. Clinical use of unfractionated heparin therapy in children: time for change?
    Newall F, Ignjatovic V, Johnston L, Summerhayes R, Lane G, Cranswick N, Monagle P.
    Br J Haematol; 2010 Sep; 150(6):674-8. PubMed ID: 20629660
    [Abstract] [Full Text] [Related]

  • 2. Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparin.
    Newall F, Ignjatovic V, Johnston L, Summerhayes R, Lane G, Cranswick N, Monagle P.
    Thromb Haemost; 2010 May; 103(5):1085-90. PubMed ID: 20174762
    [Abstract] [Full Text] [Related]

  • 3. Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay.
    Kitchen S, Theaker J, Preston FE.
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):137-44. PubMed ID: 10759006
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
    Guervil DJ, Rosenberg AF, Winterstein AG, Harris NS, Johns TE, Zumberg MS.
    Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
    [Abstract] [Full Text] [Related]

  • 7. A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoring.
    Vandiver JW, Vondracek TG.
    Hosp Pract (1995); 2013 Apr; 41(2):16-24. PubMed ID: 23545756
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The PiCT® test is a reliable alternative to the activated partial thromboplastin time in unfractionated heparin therapy management: results from a multicenter study.
    Brisset AC, Ferrández A, Krause M, Rathbun S, Marlar R, Korte W.
    J Thromb Haemost; 2016 Nov; 14(11):2187-2193. PubMed ID: 27582411
    [Abstract] [Full Text] [Related]

  • 13. Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparin.
    Toulon P, Boutière B, Horellou MH, Trzeciak MC, Samama MM.
    Thromb Haemost; 1998 Jul; 80(1):104-8. PubMed ID: 9684794
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D, Långström S, Petäjä J, Heikinheimo M, Pihkala J.
    Catheter Cardiovasc Interv; 2013 Jun 01; 81(7):1174-9. PubMed ID: 22915548
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically ill children.
    Kuhle S, Eulmesekian P, Kavanagh B, Massicotte P, Vegh P, Lau A, Mitchell LG.
    Haematologica; 2007 Apr 01; 92(4):554-7. PubMed ID: 17488668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.